Study evaluates androgen deprivation therapy for prostate cancer
Links shared publicly online about this topic.
- 665total visits
Study evaluates androgen deprivation therapy for prostate cancer
View full resource at prostate-report.org
Tags: Cancer, Prostate Cancer, Prostate, Men's Health
Most Recently Shared on December 10, 2010 at 8:39 pm By:
Study evaluates androgen deprivation therapy for prostate cancer: Androgen deprivation therapy (ADT) is a hormon... http://bit.ly/dW2QFS
Oncology News - A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy |3990451
mdlinx.com — “Oncology Medical Article: A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy” View full resource at mdlinx.com
Most Recently Shared on March 23, 2012 at 6:11 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy: BMC Cancer http://t.co/OPDhda1D #oncology
Prostate Tumor Growth May Be Slowed By Curry Spice Component
medicalnewstoday.com — “Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy (ADT), a study fr” View full resource at medicalnewstoday.com
Most Recently Shared on February 14, 2012 at 8:05 am By:
Prostate Tumor Growth May Be Slowed By Curry Spice Component http://t.co/FmdIGYsy #prostate
Curry spice component may help slow prostate tumor growth
medicalxpress.com — “Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy (ADT), a study from researchers at Jefferson's Kimmel Cancer Center suggests.” View full resource at medicalxpress.com
Most Recently Shared on February 10, 2012 at 3:58 pm By:
Curry spice component may help slow prostate tumor growth http://t.co/z8TSIB1t
Symposier - Prostate cancer hormone treatment heart risks | Dana-Farber Cancer Institute
symposier.com — “Uploaded and shared in Youtube by: DanaFarberCancerInst — Recent studies had suggested that hormone-blocking therapy for prostate cancer could raise the risk of fatal heart attacks. Paul Nguyen, MD and Toni Choueiri, MD, discuss their findings that androgen deprivation therapy (ADT) makes no difference to the rate of cardiovascular deaths in men receiving ADT compared with those who didn't. There is still a question of whether ADT elevates the risk of fatal heart attacks in patients with a ” View full resource at symposier.com
Most Recently Shared on December 15, 2011 at 4:54 am By:
Symposier Endocrino Health Site
Association of Androgen Deprivation Therapy with Cardiovascular Death in PTs with Prostate Cancer http://t.co/XmmBYO5x
Prostate Cancer - Androgen Deprivation Therapy Does Not Raise Cardiovascular Death Risk
medicalnewstoday.com — “A study published in the December issue of JAMA shows that even though earlier investigations suggested that androgen deprivation therapy designed to inhibit the production of male sex horm” View full resource at medicalnewstoday.com
Most Recently Shared on December 8, 2011 at 3:05 pm By:
Prostate Cancer - Androgen Deprivation Therapy Does Not Raise Cardiovascular Death Risk http://t.co/2YWSis4r #prostate
ADT Use Declining, Patterns of Use Changing - Renal and Urology News
renalandurologynews.com — “Initiation of androgen deprivation therapy (ADT) for prostate cancer (PCa) is declining and patterns of use are changing, according to recently published data from a Canadian study.” View full resource at renalandurologynews.com
Most Recently Shared on November 28, 2011 at 3:55 pm By:
Renal Urology News Nephrology, Urology, Medical Publisher, and Health News
ADT Use Declining, Patterns of Use Changing. http://t.co/0oFVcs0X #Prostate #Cancer #News #HCsm
Obesity Raises Metastasis Risk in Prostate Cancer Patients on ADT - Renal and Urology News
renalandurologynews.com — “Obesity is associated with an increased risk for prostate cancer (PCa) progression among PCa patients treated with androgen deprivation therapy (ADT) after radical prostatectomy, according to a study.” View full resource at renalandurologynews.com
Most Recently Shared on November 28, 2011 at 3:21 pm By:
Renal Urology News Nephrology, Urology, Medical Publisher, and Health News
Obesity Raises Metastasis Risk in Prostate Cancer Patients on ADT. http://t.co/ZzJC3Ktp #Obesity #Health #News #HCsm
Androgen Deprivation for Prostate Cancer | Now@NEJM
blogs.nejm.org — “In a new study by Jones et al., Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer, a course of androgen-deprivation therapy before” View full resource at blogs.nejm.org
Most Recently Shared on July 15, 2011 at 5:07 pm By:
NEJM: Androgen Deprivation for Prostate Cancer http://bit.ly/nFdqOE
NEJM: ADT lowers prostate cancer mortality
healthimaging.com — “Androgen-deprivation therapy (ADT) delivers a clear survival improvement for patients suffering from early localized prostate cancer, benefiting intermediate-risk patients in particular while reducing mortality equally for whites and blacks, according to a study published July 14 in The New England Journal of Medicine.” View full resource at healthimaging.com
Most Recently Shared on July 14, 2011 at 6:35 pm By:
Health Imaging & IT Health Magazine
Study: ADT lowers prostate cancer mortality - Androgen-deprivation therapy (ADT) delivers a clear survival improveme... http://ow.ly/1dOiHN
Short-Term Hormone Therapy Plus Radiation Therapy Increases Survival for Men with Early-Stage Prostate Cancer
newswise.com — “Short-term hormone therapy (androgen deprivation therapy: ADT) given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group (RTOG) study published in the July 14 issue of the New England Journal of Medicine.” View full resource at newswise.com
Most Recently Shared on July 13, 2011 at 9:37 pm By:
newswise Health Communicator and Health News
Short-Term Hormone Therapy Plus Radiation Therapy Increases Survival for Men with Early-Stage Prostate Cancer: S... http://bit.ly/ovjCrl
Large Randomized Phase III Clinical Trial Shows Short-Term Hormone Therapy Plus Radiation Therapy Increases Survival for Men With Early-Stage Prostate Cancer
acr.org — “Philadelphia (July 13, 2011) — Short-term hormone therapy (androgen deprivation therapy: ADT) given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group (RTOG) study published in the July 14 issue of the New England Journal of Medicine.” View full resource at acr.org
Most Recently Shared on July 13, 2011 at 9:02 pm By:
Short-Term #HormoneTherapy Plus #RadiationTherapy Increases Survival for Men With Early-Stage #ProstateCancer http://t.co/ofnD6uO
Short-Term Hormone Therapy Plus Radiation Therapy Increases Survival for Men with Early-Stage Prostate Cancer
newswise.com — “Short-term hormone therapy (androgen deprivation therapy: ADT) given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group (RTOG) study published in the July 14 issue of the New England Journal of Medicine.” View full resource at newswise.com
Most Recently Shared on July 13, 2011 at 9:02 pm By:
Short-Term Hormone Therapy Plus Radiation Therapy Increases Survival for Men with Early-Stage Prostate C... http://bit.ly/p1hyiT #cancer
Filipino study links prostate hormone therapy, diabetes - Related Stories - DiabetesPro SmartBrief
smartbrief.com — “Patients with prostate cancer who received androgen deprivation therapy were twice as likely to develop diabetes than their nontreated counterparts, Filipino researchers said. The results presented at the annual meeting of The Endocrine Society show that 42% of the hormone therapy group developed d…” View full resource at smartbrief.com
Most Recently Shared on June 10, 2011 at 8:01 am By:
Hormone therapy for prostate cancer may raise type 2 diabetes risk
endocrineweb.com — “Androgen deprivation therapy (ADT) is a common treatment for men with aggressive forms of prostate cancer and has saved countless lives. However, a new study from a team of Philippine researchers suggests that the treatment may also raise a man's risk of type 2 diabetes.Testosterone is known to fuel the growth of prostate tumors.” View full resource at endocrineweb.com
Most Recently Shared on June 9, 2011 at 5:10 pm By:
Hormone therapy for prostate cancer may raise type 2 diabetes risk http://bit.ly/iTslib
Hormone therapy for prostate cancer may raise type 2 diabetes risk
endocrineweb.com — “Androgen deprivation therapy (ADT) is a common treatment for men with aggressive forms of prostate cancer and has saved countless lives. However, a new study from a team of Philippine researchers suggests that the treatment may also raise a man's risk of type 2 diabetes.Testosterone is known to fuel the growth of prostate tumors.” View full resource at endocrineweb.com
Most Recently Shared on June 9, 2011 at 4:30 pm By:
Hormone therapy for prostate cancer may raise type 2 diabetes risk http://dlvr.it/VhbxG
Advertisement
